Connors; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Connors; Mark.The latest application filed is for "neutralizing antibodies to hiv-1 gp41 and their use".

Company Profile

11.17.23

Connors; Mark - Bethesda MD
CONNORS; Mark - Rockville MD
Connors; Mark - Chevy Chase MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use App 20220098286 - Kwong; Peter ; et al.	2022-03-31
Human Immunodeficiency Virus-specific T Cell Receptors App 20220098268 - RHODE; Peter ; et al.	2022-03-31
Neutralizing antibodies to HIV-1 GP41 and their use Grant 11,236,152 - Kwong , et al. February 1, 2	2022-02-01
Neutralizing Antibodies To Gp120 And Their Use App 20210324053 - Connors; Mark ; et al.	2021-10-21
Trispecific Binding Proteins, Methods, And Uses Thereof App 20200399369 - ASOKAN; Mangaiarkarasi ; et al.	2020-12-24
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,815,295 - Kwong , et al. October 27, 2	2020-10-27
Neutralizing Antibodies To Gp120 And Their Use App 20200231658 - Connors; Mark ; et al.	2020-07-23
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of Hiv Infection App 20200054765 - YANG; Zhi-Yong ; et al.	2020-02-20
Neutralizing antibodies to gp120 and their use Grant 10,562,960 - Connors , et al. Feb	2020-02-18
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use App 20190077849 - Kwong; Peter ; et al.	2019-03-14
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of Hiv Infection App 20190054182 - YANG; Zhi-Yong ; et al.	2019-02-21
Broadly Neutralizing Hiv-1 Antibodies That Bind To The Cd4-binding Site Of The Envelope Protein App 20190016786 - Kwong; Peter D. ; et al.	2019-01-17
Neutralizing Antibodies To Gp120 And Their Use App 20180298083 - Connors; Mark ; et al.	2018-10-18
Neutralizing GP41 antibodies and their use Grant 10,047,148 - Connors , et al. August 14, 2	2018-08-14
Neutralizing GP41 antibodies and their use Grant 10,047,147 - Connors , et al. August 14, 2	2018-08-14
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,035,844 - Kwong , et al. July 31, 2	2018-07-31
Neutralizing antibodies to HIV-1 and their use Grant 10,035,845 - Mascola , et al. July 31, 2	2018-07-31
Neutralizing Gp41 Antibodies And Their Use App 20180002406 - Connors; Mark ; et al.	2018-01-04
Neutralizing Antibodies To Hiv-1 And Their Use App 20170369558 - Mascola; John ; et al.	2017-12-28
Neutralizing GP41 antibodies and their use Grant 9,783,595 - Connors , et al. October 10, 2	2017-10-10
Neutralizing Antibodies To Hiv-1 And Their Use App 20170267748 - Kwong; Peter D. ; et al.	2017-09-21
Neutralizing antibodies to HIV-1 and their use Grant 9,738,703 - Mascola , et al. August 22, 2	2017-08-22
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 9,695,230 - Kwong , et al. July 4, 2	2017-07-04
Neutralizing Gp41 Antibodies And Their Use App 20160333076 - Connors; Mark ; et al.	2016-11-17
Neutralizing GP41 antibodies and their use Grant 9,475,862 - Connors , et al. October 25, 2	2016-10-25
Neutralizing Antibodies To Hiv-1 And Their Use App 20160009789 - Mascola; John ; et al.	2016-01-14
Neutralizing antibodies to HIV-1 and their use Grant 9,175,070 - Mascola , et al. November 3, 2	2015-11-03
Neutralizing Antibodies To Hiv-1 And Their Use App 20150044137 - Mascola; John R. ; et al.	2015-02-12
Neutralizing Gp41 Antibodies And Their Use App 20140348785 - Connors; Mark ; et al.	2014-11-27
Neutralizing Gp41 Antibodies And Their Use App 20140342407 - Connors; Mark ; et al.	2014-11-20
Neutralizing Antibodies To Hiv-1 And Their Use App 20140322163 - Kwong; Peter D. ; et al.	2014-10-30
Neutralizing antibodies to HIV-1 and their use Grant 8,637,036 - Mascola , et al. January 28, 2	2014-01-28
Neutralizing Antibodies To Hiv-1 And Their Use App 20120282264 - Mascola; John R. ; et al.	2012-11-08
Neutralizing Antibodies To Hiv-1 And Their Use App 20120244166 - Mascola; John R. ; et al.	2012-09-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20120237523 - Mascola; John R. ; et al.	2012-09-20
Induction Of Proliferation, Effector Molecule Expression, And Cytolytic Capacity Of Hiv-specific Cd8+ T Cells App 20110052631 - Connors; Mark ; et al.	2011-03-03
Attenuated respiratory syncytial virus vaccine compositions Grant 5,922,326 - Murphy , et al. July 13, 1	1999-07-13
Attenuated respiratory syncytial virus vaccine compositions Grant 5,882,651 - Murphy , et al. March 16, 1	1999-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.